Variantyx

📍 Framingham, United States🗓 Founded 2014👥 221 employees💰 Last funded Oct 2021
Medical and Diagnostic Laboratories🌐 variantyx.com
Website LinkedIn
Variantyx is a technology-driven precision medicine company providing state-of-the-art diagnostic solutions for the rare genetic disorders and reproductive genetics markets, and treatment optimization in oncology. Our unique, comprehensive testing platform uses whole genome sequencing to identify all major genetic changes from a single sample. The results empower patients and providers with information that can rapidly end the challenging diagnostic search, optimize treatment, and improve quality of life. We are a diverse, multinational company that embodies professionalism, transparency, tenacity, and respect. See more with us: www.variantyx.com/.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Israel
1
Germany
1
Frequently asked questions
Who invested in Variantyx?
Variantyx has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Variantyx last raise funding?
The most recent investment in Variantyx recorded on gritt.io was in October 2021.
When was Variantyx founded?
Variantyx was founded in 2014.
What industry is Variantyx in?
Variantyx operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is Variantyx based?
Variantyx is headquartered in Framingham, United States.